Urothelial cancer II: Non-muscle invasive, muscle invasive and UUT

  • Location:
    Warsaw Halls
  • Chairs:
     M. Colombel, Lyon, Cedex 3 (FR)
     J. Palou, Barcelona (ES)
     B. Malavaud, Toulouse (FR)
     L. Türkeri, Istanbul (TR)
  • Panel:
     E. Compérat, Paris (FR)
     P. Gontero, Turin (IT)
     L.P. Nyk, Warsaw (PL)
     S. Osanto, Leiden (NL)
Alternative adjuvant treatments for NMIBC in the BCG shortage era
 J. Palou, Barcelona (ES)
Discussion
Challenging the EAU Guidelines Neo-adjuvant chemotherapy for MIBC should be administered: Pro/Con
Pro
 G. Gakis, Tübingen (DE)
Con
 G.N. Thalmann, Bern (CH)
Discussion
Salvage cystectomy after radiotherapy: Type of diversion and morbidity
 J.W.F. Catto, Sheffield (GB)
Discussion
MDT in uro-oncology Difficult cases in high risk urothelial cancer